peptide 1 glp 1 Glucagon-like peptide-1 (GLP-1), released from the intestine, informs GLP-1 (7-36) amide | Sterile

Blood samples were obtained at indicated time-points, and glucose measured using a Contour glucose meter (Bayer)

Exenatide has a relatively short half-life, (6090 min in humans, Kolterman et al., 2005) and is recommended for twice-daily administration

1 2 Harrison's principles of internal medicine (18th ed.)

Glucagon-like peptide-1 (GLP-1) agonist therapies are increasingly being used for type 2 diabetes and obesity, but evidence now shows they also reduce inflammation across multiple organs through mechanisms related and unrelated to weight-loss-driven metabolic improvements

Combined- versus single-compound repair pathway comparisons